Literature DB >> 1469160

Continuous arteriovenous haemofiltration and respiratory function in multiple organ systems failure.

O N Bagshaw1, F R Anaes, A Hutchinson.   

Abstract

OBJECTIVE: To determine what change in respiratory function occurred following prolonged and efficient continuous arteriovenous haemofiltration (CAVH) in a group of patients with multiple organ systems failure (MOSF).
DESIGN: A retrospective assessment using patient notes and ICU charts.
SETTING: The Intensive Care Unit of a large University Teaching Hospital. PATIENTS: All ICU patients satisfying the following criteria: (i) Failure of more than one organ system; (ii) Treatment with CAVH; (iii) Removal of more than 10 l of ultrafiltrate per day; (iv) Continuous haemofiltration for at least 5 days. Thirteen patients satisfied these criteria and 14 episodes of CAVH were analyzed. MEASUREMENTS: All data were recorded from the patient notes and ICU charts apart from the A-aDO2 and PaO2/FiO2 (PF) ratio which were calculated from available values. A mean of 3.5 different organ systems failed during the period of stay. The mean daily ultrafiltrate volume obtained was 23.7 (SD 0.95) l and the mean duration of treatment 9.6 (SD 4.3) days. Significant improvements occurred in the values for the PF ratio and ventilatory modality (p < 0.05), and the FiO2 and A-aDO2 (p = 0.001). The mean PEEP value remained unchanged at 4.8 cmH2O. Ten of the 13 patients subsequently died (77% mortality).
CONCLUSIONS: A significant improvement in respiratory function occurred in patients with MOSF who had undergone a prolonged period of intensive CAVH. Haemofiltration may therefore be a useful treatment for respiratory failure in this patient group. Unfortunately the overall mortality of the group remained high.

Entities:  

Mesh:

Year:  1992        PMID: 1469160     DOI: 10.1007/bf01694361

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  26 in total

1.  Use of extracorporeal supportive techniques as additional treatment for septic-induced multiple organ failure patients.

Authors:  E Barzilay; D Kessler; G Berlot; A Gullo; D Geber; I Ben Zeev
Journal:  Crit Care Med       Date:  1989-07       Impact factor: 7.598

2.  Effects of furosemide versus isolated ultrafiltration on extravascular lung water in oleic acid-induced pulmonary edema.

Authors:  E D Sivak; J Tita; G Meden; M Ishigami; J Graves; J Kavlich; N T Stowe; M O Magnusson
Journal:  Crit Care Med       Date:  1986-01       Impact factor: 7.598

3.  Prognosis in acute organ-system failure.

Authors:  W A Knaus; E A Draper; D P Wagner; J E Zimmerman
Journal:  Ann Surg       Date:  1985-12       Impact factor: 12.969

4.  Outcome of continuous arteriovenous haemofiltration (CAVH) in one centre.

Authors:  A A Alarabi; B G Danielson; B Wikström; J Wahlberg
Journal:  Ups J Med Sci       Date:  1989       Impact factor: 2.384

5.  Use of prostacyclin and ultrafiltration in adult respiratory distress syndrome.

Authors:  A Richardson; F C Wells; M A Branthwaite
Journal:  Intensive Care Med       Date:  1984       Impact factor: 17.440

6.  Continuous arteriovenous hemofiltration. A report of six months' experience.

Authors:  A A Kaplan; R E Longnecker; V W Folkert
Journal:  Ann Intern Med       Date:  1984-03       Impact factor: 25.391

7.  Continuous arteriovenous filtration: an effective treatment for surgical acute renal failure.

Authors:  J R Mault; R E Dechert; P Lees; R D Swartz; F K Port; R H Bartlett
Journal:  Surgery       Date:  1987-04       Impact factor: 3.982

8.  Continuous arteriovenous hemofiltration in the treatment of 100 critically ill patients with acute renal failure: report on clinical outcome and nutritional aspects.

Authors:  L Weiss; B G Danielson; B Wikström; U Hedstrand; J Wahlberg
Journal:  Clin Nephrol       Date:  1989-04       Impact factor: 0.975

9.  Continuous arteriovenous hemofiltration as an adjunctive therapy for septic shock.

Authors:  G J Ossenkoppele; J van der Meulen; W Bronsveld; L G Thijs
Journal:  Crit Care Med       Date:  1985-02       Impact factor: 7.598

10.  Causes of mortality in patients with the adult respiratory distress syndrome.

Authors:  A B Montgomery; M A Stager; C J Carrico; L D Hudson
Journal:  Am Rev Respir Dis       Date:  1985-09
View more
  5 in total

Review 1.  Removal of pro-inflammatory cytokines with renal replacement therapy: sense or nonsense?

Authors:  M Schetz; P Ferdinande; G Van den Berghe; C Verwaest; P Lauwers
Journal:  Intensive Care Med       Date:  1995-02       Impact factor: 17.440

2.  Treatment of surgical and non-surgical septic multiorgan failure with bicarbonate hemodialysis and sequential hemofiltration.

Authors:  L Gotloib; A Shostak; A Lev; R Fudin; J Jaichenko
Journal:  Intensive Care Med       Date:  1995-02       Impact factor: 17.440

3.  Impact of continuous renal replacement therapy on oxygenation in children with acute lung injury after allogeneic hematopoietic stem cell transplantation.

Authors:  Lama Elbahlawan; Nancy K West; Yvonne Avent; Cheng Cheng; Wei Liu; Raymond C Barfield; Deborah P Jones; Surender Rajasekaran; R Ray Morrison
Journal:  Pediatr Blood Cancer       Date:  2010-09       Impact factor: 3.167

4.  Cortisol and catecholamine kinetics during continuous hemodiafiltration in patients with multiple organ dysfunction syndrome.

Authors:  T Tsubo; Y Hashimoto; I Araki; H Ishihara; A Matsuki
Journal:  Intensive Care Med       Date:  1996-11       Impact factor: 17.440

5.  Improvement of Oxygenation in Severe Acute Respiratory Distress Syndrome With High-Volume Continuous Veno-venous Hemofiltration.

Authors:  Wenmin Yang; Jie Hong; Qiyi Zeng; Jianping Tao; Feiyan Chen; Run Dang; Yufeng Liang; Zhiyuan Wu; Yiyu Yang
Journal:  Glob Pediatr Health       Date:  2016-05-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.